Mortality Benefits of ACE Inhibition in Patients With Coronary Artery Disease
Reproduced from Bertrand ME et al. Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA study. Am Heart J 2010; 159(5):795–802. With permission from Elsevier.